MDRI Current Studies
Qualified study participants will receive study drug, related testing, and compensation for their time and travel.
Psoriasis Clinical Trials |
Eczema Clinical Trials |
| Boehringer-Ingelheim | Merck 8226-003 |
| Pfizer 1082 | Regeneron |
| Galderma – Pediatric |
Symbio M518101 |
| Symbio M518101 |
Translational Research Protocols in Collaboration with the Baylor Institute for Immunology Research (BIIR)
• Evaluation of cardiovascular risk using coronary artery calcium scores in psoriasis patients;
Baylor IRB #: 013-156
• Immune signatures of psoriasis and other skin disorders; Baylor IRB #: 007-024